Results 301 to 310 of about 138,544 (375)

Risk of anaphylaxis after vaccination in children and adults.

Journal of Allergy and Clinical Immunology, 2016
M. McNeil, Eric S. Weintraub, J. Duffy, Lakshmi Sukumaran, S. Jacobsen, N. Klein, S. Hambidge, Grace M. Lee, L. Jackson, Stephanie A. Irving, J. King, E. Kharbanda, R. Bednarczyk, F. Destefano   +13 more
semanticscholar   +1 more source

Patient‐derived tumor organoids highlight the potential of precision medicine in managing pancreatic ductal adenocarcinoma

International Journal of Cancer, Volume 157, Issue 4, Page 760-772, 15 August 2025.
What's new? Only about one‐fifth of patients with pancreatic ductal adenocarcinoma (PDAC) qualify for curative treatment approaches employing adjuvant chemotherapy. Tools to predict PDAC response to chemotherapeutic regimens, however, are lacking.
Christine Nitschke, Charline Phan, Yara Souto, Philipp Walter, Mara Goetz, Gediminas Simkus, Jacob Thastrup, Ronald Simon, Jürgen Kupper, Jakob Izbicki, Steven A. Johnsen, Thilo Hackert, Marianne Sinn, Harriet Wikman, Faik G. Uzunoglu, Tabea M. Sturmheit   +15 more
wiley   +1 more source

Anaphylaxis [PDF]

The Permanente Journal, 2007
openaire   +2 more sources

Microarray Patch Based Transdermal Allergen Immunotherapy Prevents Gliadin-induced Anaphylaxis in a Murine Model. [PDF]

Allergy Asthma Immunol Res
Liang L, Hwang AR, Guon TE, Park KH, Park CO, Lee JH, Park JW.   +6 more
europepmc   +1 more source

Confirmation of Fixed Quarterly Riliprubart Regimen in Patients with Cold Agglutinin Disease Using Population PK/PD and Exposure‐Response Analyses

Clinical Pharmacology &Therapeutics, Volume 118, Issue 2, Page 449-458, August 2025.
Riliprubart is a second‐generation, humanized immunoglobulin G4 that inhibits only the activated form of the C1s component of the proximal classical complement pathway. The clinical studies of riliprubart conducted thus far for the treatment of cold agglutinin disease (CAD), a rare autoimmune disease, include a Phase 1 first‐in‐human study in healthy ...
Timothy Chow, Marek Wardecki, Michael Storek, Nancy Wong   +3 more
wiley   +1 more source

Experimental study on anaphylaxis of guinea-pigs by the technick of perfusing blood-vessels of hind limbs.

, 1950
Kazuyoshi Morimoto
openalex   +2 more sources

Fire ant-venom anaphylaxis prevalence in the general population and patients with systemic mastocytosis. [PDF]

Front Allergy
McMurray JC, Schornack BJ, Adams KE, McCoy RL, Marshall AK, Brunader JA, Maric I, Metcalfe DD, Boggs NA.   +8 more
europepmc   +1 more source

Contact Urticaria and Related Conditions: Clinical Review

Contact Dermatitis, Volume 93, Issue 2, Page 87-107, August 2025.
ABSTRACT Contact urticaria (CoU) is an immediate contact reaction occurring within minutes to an hour after exposure to specific proteins or chemicals. CoU is categorised into non‐immunologic (NI‐CoU) and immunologic (I‐CoU) types, with I‐CoU potentially leading to anaphylaxis. Both forms of CoU can be associated with protein contact dermatitis and the
Mojca Bizjak, Olivier Aerts, David Pesqué, Melba Muñoz, Riccardo Asero, Margarida Gonçalo, Thomas Rustemeyer, Mitja Košnik, Mark Kačar, An Goossens, Jose Hernán Alfonso, Charlotte G. Mortz, Maryam Ali Al‐Nesf, Joachim W. Fluhr, Howard I. Maibach, Ana Maria Giménez‐Arnau   +15 more
wiley   +1 more source

Studies on the sensitizations period of passive anaphylaxis

, 1954
Keizo Yamasita
openalex   +2 more sources

Editorial: Women in science: allergy research. [PDF]

Front Allergy
Carreras-Badosa G, Esteban V, Hernandez-Trujillo V, Toskala E, Mukherjee M, Al Heialy S, Fieten K.   +6 more
europepmc   +1 more source